Alcon Pharmaceuticals, Ltd.
USPTO PatentsView assignee record - 20 granted patents across 8 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Alcon ranks #14,446 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 8 technology areas.
- #14,446
- of 49,997 US assignees by volume
- 39th percentile
- by Innovation Score (31.8/100)
- 15.7
- avg claims per patent
- -82%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R14446 · Foreign Corporation #14,446 · 20 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 20 grants
- MID-PACK #14,446/49,997
- PHOTO-FINISH Airgas
- CPC-NARROW A61F · 8 areas
- INNOV-THIN 31.8/100
- CLAIMS-RICH 15.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -82% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Airgas, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Alcon’s 31.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Alcon
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Alcon Pharmaceuticals · this assignee 32
Alcon Pharmaceuticals · this assignee
32 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Alcon's Innovation Score is 31.8/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Alcon?
Each dot is one of Alcon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alcon’s own 15.7 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Alcon's grants concentrate
Alcon Pharmaceuticals, Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 60% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2017. By volume, Alcon sits between AirStrip IP Holdings, LLC and Amlogic Co., Limited.
Alcon's three-year grant acceleration
Alcon Pharmaceuticals, Ltd. shows 2 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Alcon's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Airstrip IP Holdi…
AirStrip IP Holdings, LLC
20 patents
- Airgas
Airgas, Inc.
20 patents
- Akron Brass
Akron Brass Company
20 patents
- Akston Biosciences
Akston Biosciences Corporation
20 patents
- Aleris Rolled Pro…
Aleris Rolled Products Germany GmbH
20 patents
- Allot
Allot Ltd.
20 patents
- Aloys F Dornbrach…
Aloys F. Dornbracht GmbH & Co. KG
20 patents
- Amlogic
Amlogic Co., Limited
20 patents
- Alcon Pharmaceuti… ◀
Alcon Pharmaceuticals, Ltd.
20 patents
What this shows Alcon holds 20 patents at rank #14,462, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Alcon
By rank, the assignees closest to #14,462 in granted patent volume.
- AirStrip IP Holdings, LLC #14,458 · 20 patents
- Airgas, Inc. #14,459 · 20 patents
- Akron Brass Company #14,460 · 20 patents
- Akston Biosciences Corporation #14,461 · 20 patents
- Aleris Rolled Products Germany GmbH #14,463 · 20 patents
- Allot Ltd. #14,464 · 20 patents
- Aloys F. Dornbracht GmbH & Co. KG #14,465 · 20 patents
- Amlogic Co., Limited #14,466 · 20 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Alcon's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Alcon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 39th percentile higher than 39% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 25.0% |
| 2016 | 3 | 15.0% |
| 2017 | 1 | 5.0% |
| 2018 | 2 | 10.0% |
| 2019 | 6 | 30.0% |
| 2020 | 1 | 5.0% |
| 2023 | 1 | 5.0% |
| 2024 | 1 | 5.0% |
Which technologies does Alcon Pharmaceuticals, Ltd. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Alcon Pharmaceuticals, Ltd.'s patent record in context - here's where to go next.
- Alcon Pharmaceuticals, Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 60% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #14,446 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Alcon Pharmaceuticals, Ltd. against AirStrip IP Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.